FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ted Splinter

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sílvia Mamede; Remy M J P Rikers; Ted A W Splinter; Tamara van Gog; Henk G Schmidt
Exploring the role of salient distracting clinical features in the emergence of diagnostic errors and the mechanisms through which reflection counteracts mistakes.
Louise C Urlings-Strop; Theo Stijnen; Axel P N Themmen; Ted A W Splinter
Selected medical students achieve better than lottery-admitted students during clerkships.
Karen M Stegers-Jager; Janke Cohen-Schotanus; Ted A W Splinter; Axel P N Themmen
Academic dismissal policy for medical students: effect on study progress and help-seeking behaviour.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ted Splinter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sílvia Mamede; Remy M J P Rikers; Ted A W Splinter; Tamara van Gog; Henk G Schmidt
Exploring the role of salient distracting clinical features in the emergence of diagnostic errors and the mechanisms through which reflection counteracts mistakes.
BMJ quality & safety 2012;21(4):295-300.
2011: Louise C Urlings-Strop; Theo Stijnen; Axel P N Themmen; Ted A W Splinter
Selected medical students achieve better than lottery-admitted students during clerkships.
Medical education 2011;45(10):1032-40.
2011: Karen M Stegers-Jager; Janke Cohen-Schotanus; Ted A W Splinter; Axel P N Themmen
Academic dismissal policy for medical students: effect on study progress and help-seeking behaviour.
Medical education 2011;45(10):987-94.
2010: Sílvia Mamede; Henk G Schmidt; Remy M J P Rikers; Eugene J F M Custers; Ted A W Splinter; Jan L C M van Saase
Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expert.
Psychological research 2010;74(6):586-92.
2009: Marye J Sonderen; Eddie Denessen; Olle Th J Ten Cate; Ted A W Splinter; Cornelis T Postma
The clinical skills assessment for international medical graduates in The Netherlands.
Medical teacher 2009;31(11):e533-8.
2009: Ted A W Splinter
[Training didactic skills during medical education. Not helpful].
Nederlands tijdschrift voor geneeskunde 2009;153(14):642.
2009: Louise C Urlings-Strop; Theo Stijnen; Axel P N Themmen; Ted A W Splinter
Selection of medical students: a controlled experiment.
Medical education 2009;43(2):175-83.
2007: Paul Wimmers; Ted A W Splinter; Gregory R Hancock; Henk G Schmidt
Clinical competence: general ability or case-specific?
Advances in health sciences education : theory and practice 2007;12(3):299-314.
2007: Jan P van Meerbeeck; Gijsbert W P M Kramer; Paul E Y Van Schil; Catherine Legrand; Egbert F Smit; Franz Schramel; Vivianne C G Tjan-Heijnen; Bonne Biesma; Channa Debruyne; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Journal of the National Cancer Institute 2007;99(6):442-50.
2006: Ted A W Splinter
[The medical curriculum need not take the religious beliefs and cultural background of the students into consideration].
Nederlands tijdschrift voor geneeskunde 2006;150(49):2721.
2006: Claire Siemes; Loes E Visser; J W W Coebergh; Ted A W Splinter; Jacqueline C M Witteman; André G Uitterlinden; Albert Hofman; Huibert A P Pols; Bruno H Ch Stricker
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5216-22.
2006: Gijsbert W P M Kramer; Catherine L Legrand; Paul Van Schil; Lon Uitterhoeve; Egbert F Smit; Franz Schramel; Bonne Biesma; Vivianne C G Tjan-Heijnen; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone; Jan P van Meerbeeck
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1391-8.
2006: Paul Wimmers; Henk G Schmidt; Ted A W Splinter
Influence of clerkship experiences on clinical competence.
Medical education 2006;40(5):450-8.
2005: Paul Van Schil; Jan P van Meerbeeck; G Kramer; Ted A W Splinter; Catherine Legrand; G Giaccone; C Manegold; nico van zandwijk
Morbidity and mortality in the surgery arm of EORTC 08941 trial.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(2):192-7.
2003: Marco B Polee; W C J Hop; TC Kok; Ferry A L M Eskens; M E L van der Burg; Ted A W Splinter; Peter D Siersema; Hugo W Tilanus; Gerrit Stoter; Ate van der Gaast
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy.
British journal of cancer 2003;89(11):2045-50.
2003: M E R O'Brien; Ted A W Splinter; Egbert F Smit; Bonne Biesma; Maciej Krzakowski; Vivianne C G Tjan-Heijnen; Aart van Bochove; J Stigt; M J A Smid-Geirnaerdt; Channa Debruyne; Catherine Legrand; Giuseppe Giaccone
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).
European journal of cancer (Oxford, England : 1990) 2003;39(10):1416-22.
2002: Marco B Polee; Jaap Verweij; Peter D Siersema; Hugo W Tilanus; Ted A W Splinter; Gerrit Stoter; Ate van der Gaast
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(11):1495-500.
2002: Marco B Polee; Ferry A L M Eskens; M E L van der Burg; Ted A W Splinter; Peter D Siersema; Hugo W Tilanus; Jaap Verweij; Gerrit Stoter; Ate van der Gaast
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer.
British journal of cancer 2002;86(5):669-73.
2001: Marco B Polee; TC Kok; Peter D Siersema; Hugo W Tilanus; Ted A W Splinter; Gerrit Stoter; Ate van der Gaast
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus.
Anti-cancer drugs 2001;12(6):513-7.
2001: Florence Duffaud; M E L van der Burg; M Namer; Ignace Vergote; W ten Bokkel Huinink; J P Guastalla; Pierre Kerbrat; M Piccart; Salvatore Tumolo; Giuseppe Favalli; N van der Vange; AJ Lacave; Jacques A Wils; Ted A W Splinter; N Einhorn; K J Roozendaal; R Rosso; Jan B Vermorken
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study.
Anti-cancer drugs 2001;12(2):159-62.
2000: Ted A W Splinter; P E van Schil; Gijsbert W P M Kramer; J van Meerbeeck; A Gregor; Pierre Rocmans; A Kirkpatrick
Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941.
Clinical lung cancer 2000;2(1):69-72; discussion 73.
2000: M Salden; Ted A W Splinter; Harry A Peters; Maxime P Look; Mieke Timmermans; Jan P van Meerbeeck; John A Foekens
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):327-32.
2000: Giuseppe Giaccone; Egbert F Smit; Jan P van Meerbeeck; Ted A W Splinter; Richard P Golding; HERBERT PINEDO; D Laan; Harm van Tinteren; Pieter E Postmus
A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):109-12.
1999: Ate van der Gaast; TC Kok; L Kerkhofs; Peter D Siersema; Hugo W Tilanus; Ted A W Splinter
Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.
British journal of cancer 1999;80(7):1052-7.
1998: Vivianne C G Tjan-Heijnen; Bonne Biesma; Joost M Festen; Ted A W Splinter; A Cox; D J Th Wagener; Pieter E Postmus
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2708-14.
1998: Giuseppe Giaccone; Ted A W Splinter; Channa Debruyne; G S Kho; Pilar Lianes; nico van zandwijk; M C Pennucci; Giorgio V Scagliotti; Jan P van Meerbeeck; Q van Hoesel; Desmond Curran; TM Sahmoud; Pieter E Postmus
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2133-41.
1997: Ate van der Gaast; TC Kok; R Vos; L Kerkhofs; Ted A W Splinter
A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-82-S19-85.
1997: TM Sahmoud; Pieter E Postmus; C van Pottelsberghe; Karin Mattson; Lauri Tammilehto; Ted A W Splinter; A S T Planting; Tom G Sutedja; J van Pawel; nico van zandwijk; Paul Baas; K J Roozendaal; M Schrijver; A Kirkpatrick; M Van Glabbeke; Andrea Ardizzoni; Giuseppe Giaccone
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2211-5.
1997: Ted A W Splinter
Introduction to the treatment of lung cancer.
Seminars in oncology 1997;24(4 Suppl 12):S12-1-S12-5.
1997: Giuseppe Giaccone; Pieter E Postmus; Ted A W Splinter; M Diaz-Puente; nico van zandwijk; Giorgio V Scagliotti; Andrea Ardizzoni; Jan P van Meerbeeck; Channa Debruyne
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.
Oncology (Williston Park, N.Y.) 1997;11(4 Suppl 3):11-4.
1997: T C Kok; Ate van der Gaast; Ted A W Splinter
13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.
European journal of cancer (Oxford, England : 1990) 1997;33(1):165-6.
1996: Ted A W Splinter
Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 16):59-61.
1996: Pieter E Postmus; Giuseppe Giaccone; Channa Debruyne; TM Sahmoud; Ted A W Splinter; nico van zandwijk
Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group.
Seminars in oncology 1996;23(5 Suppl 12):10-3.
1996: T C Kok; Ate van der Gaast; J Dees; W M Eykenboom; Hans van Overhagen; Gerrit Stoter; H W Tilanus; Ted A W Splinter
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.
British journal of cancer 1996;74(6):980-4.
1996: Pieter E Postmus; Giorgio V Scagliotti; H J Groen; F Gozzelino; J T Burghouts; Desmond Curran; TM Sahmoud; A Kirkpatrick; Giuseppe Giaccone; Ted A W Splinter
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1498-503.
1996: T C Kok; Ate van der Gaast; Ted A W Splinter
5-fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Rotterdam Esophageal Tumor Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):533-4.
1996: Ted A W Splinter; M Pavone-Macaluso; D Jacqmin; J T Roberts; P Carpentier; M de Pauw; T Sahmoud
Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: prognostic factor analysis.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1129-34.
1996: Ted A W Splinter; TM Sahmoud; J Festen; nico van zandwijk; S Sörenson; M Clerico; J Burghouts; B Dautzenberg; G S Kho; A Kirkpatrick; Giuseppe Giaccone
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):127-34.
1995: Ate van der Gaast; T C Kok; G S Kho; B G Blijenberg; Ted A W Splinter
Disease monitoring by the tumour markers cyfra 21.1 and TPA in patients with non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1790-3.
1994: Ate van der Gaast; C H Schoenmakers; T C Kok; B G Blijenberg; F Cornillie; Ted A W Splinter
Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.
British journal of cancer 1994;69(3):525-8.
1994: Ate van der Gaast; C H Schoenmakers; T C Kok; B G Blijenberg; W C Hop; Ted A W Splinter
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1783-6.
1993: Ate van der Gaast; Pieter E Postmus; J Burghouts; C van Bolhuis; J Stam; Ted A W Splinter
Long term survival of small cell lung cancer patients after chemotherapy.
British journal of cancer 1993;67(4):822-4.
1993: Ate van der Gaast; C Hulshof; T C Kok; E van Loon; Ted A W Splinter
Correlation between changes in the tumour markers CA-M26 and CA-M29 and standard response evaluation in patients with metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):870-3.
1993: T van Gelder; P Geurs; G S Kho; D W Dippel; C J Vecht; Ted A W Splinter
Cortical blindness and seizures following cisplatin treatment: both of epileptic origin?
European journal of cancer (Oxford, England : 1990) 1993;29A(10):1497-8.
1993: Pieter E Postmus; Egbert F Smit; A Kirkpatrick; Ted A W Splinter
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):204-7.
1992: Ted A W Splinter; Ate van der Gaast; T C Kok
What is the optimal dose and duration of treatment with etoposide? I. Maximum tolerated duration of daily treatment with 50, 75, and 100 mg of oral etoposide.
Seminars in oncology 1992;19(6 Suppl 14):1-7.
1992: Ted A W Splinter; M Pavone-Macaluso; D Jacqmin; J T Roberts; P Carpentier; M de Pauw; R Sylvester
A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical response.
The Journal of urology 1992;148(6):1793-6.
1992: Ted A W Splinter; C F Verkoelen; M Vlastuin; T C Kok; G Rijksen; K G Haglid; F Boomsma; A van de Gaast
Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.
British journal of cancer 1992;66(6):1065-9.
1992: Ted A W Splinter
Cachexia and cancer: a clinician's view.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 3():25-7.
1992: Ate van der Gaast; Ted A W Splinter
Teniposide (VM-26) in ovarian cancer: a review.
Seminars in oncology 1992;19(2 Suppl 6):95-7.
1992: Ted A W Splinter; J J Holthuis; T C Kok; M H Post
Absolute bioavailability and pharmacokinetics of oral teniposide.
Seminars in oncology 1992;19(2 Suppl 6):28-34.
1992: Ted A W Splinter; Howard I Scher; L Denis; R Bukowski; S Simon; I Klimberg; Mark S Soloway; N J Vogelzang; H van Tinteren; Harry W Herr
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
The Journal of urology 1992;147(3):606-8.
1992: Ate van der Gaast; Wim J Kirkels; B G Blijenberg; Ted A W Splinter
Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.
Journal of cancer research and clinical oncology 1992;118(8):626-8.
1992: Pieter E Postmus; Ted A W Splinter; F M Palmen; D N Carney; J Festen; J T Burghouts; C Vendrik; K Roozendaal; A S Planting; Elisabeth Quoix
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
European journal of cancer (Oxford, England : 1990) 1992;28(1):96-100.
1991: Ate van der Gaast; W L van Putten; R Oosterom; M Cozijnsen; R Hoekstra; Ted A W Splinter
Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
British journal of cancer 1991;64(2):369-72.
1991: Ate van der Gaast; J W Hoekstra; J J Croles; Ted A W Splinter
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
The Journal of urology 1991;145(4):829-31.
1991: D J Bac; T C Kok; Ate van der Gaast; Ted A W Splinter
Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma.
Journal of cancer research and clinical oncology 1991;117(3):263-5.
1991: Ate van der Gaast; T C Kok; Ted A W Splinter
Growing teratoma syndrome successfully treated with lymphoblastoid interferon.
European urology 1991;19(3):257-8.
1991: T C Kok; Ate van der Gaast; Ted A W Splinter; H W Tilanus
Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.
European journal of cancer (Oxford, England : 1990) 1991;27(9):1112-4.
1990: Ted A W Splinter; L Denis
Restaging procedures, criteria of response, and relationship between pathological response and survival.
Seminars in oncology 1990;17(5):606-12.
1990: Ate van der Gaast; J Verwey; E Prins; Ted A W Splinter
Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas.
Cancer 1990;65(3):422-4.
1990: Ted A W Splinter; Howard I Scher; L Denis; R Bukowski; Mark S Soloway; N Vogelzang; I Klimberg; O Dalesio; Harry W Herr
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Progress in clinical and biological research 1990;353():219-24.
1990: Ted A W Splinter
Chemotherapy in advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1990;26(10):1093-9.
1989: Ate van der Gaast; T C Kok; N H van der Linden; Ted A W Splinter
Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion.
European journal of cancer & clinical oncology 1989;25(10):1505-6.
1989: Ted A W Splinter; H Obertop; T C Kok; J Jeekel
Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study.
Journal of cancer research and clinical oncology 1989;115(2):200-2.
1989: Ted A W Splinter; D N Carney; M Teeling; M D Peake; G S Kho; R Oosterom; E H Cooper
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Journal of cancer research and clinical oncology 1989;115(4):400-1.
1988: Ted A W Splinter; F J ten Kate; F H Schröder; L Denis; D Newling; W G Jones; D Jacqmin; C G Boeken Kruger; G Stoter; H J de Voogt
Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
Progress in clinical and biological research 1988;269():579-90.
1988: Ted A W Splinter; F H Schröder; L Denis; D Newling; D Jacqmin; R R Hall; M de Pauw
A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis.
European urology 1988;14 Suppl 1():24-6.
1988: Ted A W Splinter; D N Carney; M Teeling; R Oosterom
Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.
Journal of cancer research and clinical oncology 1988;114(6):641-3.
1987: Pieter E Postmus; H H Berendsen; nico van zandwijk; Ted A W Splinter; J T Burghouts; W Bakker
Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy.
European journal of cancer & clinical oncology 1987;23(9):1409-11.
1987: Ted A W Splinter; E H Cooper; G S Kho; R Oosterom; M D Peake
Neuron-specific enolase as a guide to the treatment of small cell lung cancer.
European journal of cancer & clinical oncology 1987;23(2):171-6.
1987: Ted A W Splinter; E H Cooper; R Oosterom; M D Peake; D A Brown; G S Kho
Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
European journal of respiratory diseases. Supplement 1987;149():37-44.